P&G Pharma Sale Could Bring $1 Billion To Feed Consumer Business
This article was originally published in The Tan Sheet
Executive Summary
A sale of Procter & Gamble's pharma business could fetch about $1 billion, according to an estimate by one analyst. That represents cash P&G could reinvest in its core business areas, beauty and consumer health care, at a time when the recession is impacting growth and the credit crisis is forcing some retailers to cut inventories to conserve cash